6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
ID: 36C77025Q0038Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/08ba3e9287e94c7895ec2ebf6e616b4c/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    (913) 684-0140
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77025Q0038_1.docx
    The document pertains to a federal Request for Proposal (RFP) issued by the Department of Veterans Affairs for the procurement of Sevelamer Carbonate 800MG Tablets for multiple CMOP (Consolidated Mail Outpatient Pharmacy) locations. The procurement is open to various eligible business categories, including small and veteran-owned enterprises. It outlines key contractual and delivery guidelines, including shipping requirements via USPS, invoicing procedures, and quality assurance measures. The solicitation specifies that offers must include detailed information about pharmaceutical products, including National Drug Codes (NDCs), bar code labeling requirements, product availability commitments, and compliance with the Drug Supply Chain Security Act. The document also establishes a framework for contract administration, including invoicing and tracking deliveries to ensure proper compliance and fulfillment of standards. In summary, the RFP aims to ensure efficient procurement and delivery of pharmaceuticals critical to veterans’ healthcare while maintaining compliance with federal regulations and encouraging participation from diverse businesses.
    36C77025Q0038.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The solicitation number is 36C77025Q0038, with a response deadline set for October 31, 2024. The contract is categorized under full and open competition for drugs and biologicals classified with Product Service Code 6505 and NAICS Code 325412. The required quantities span across various CMOP locations, including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston, with a total of 8,480 tablets to be supplied. Offerors must comply with the Drug Supply Chain Security Act and submit relevant documentation with their quotations. This includes their state wholesale distributor license, a signed solicitation cover page, and a Trade Agreements Act certificate. All proposals must be submitted via email to the designated contracting specialist, Kelley Cunningham. This presolicitation reflects the VA's commitment to ensuring an adequate supply of pharmaceuticals for the veteran population while adhering to regulatory and procedural guidelines.
    S02_Pricing Schedule_Q0038.xlsx
    The document outlines a Request for Quote (RFQ) from the VA for the procurement of pharmaceuticals, specifically SEVELAMER CARBONATE 800MG TAB. The solicitation, referenced by RFQ number 36C77025Q0038, has a posted date of October 25, 2024, with a closing date set for October 31, 2024, at 3:00 PM Central Time. Vendors are required to submit a signed SF1449 cover page, a completed quote spreadsheet, and relevant licenses including a State Wholesale Distributor License and a Trade Agreement Act (TAA) Certificate. The document emphasizes that only TAA compliant quotes will be considered, and specifies that all pharmaceutical products must have a minimum expiration of one year from the delivery date. It provides a line-item listing of quantities, pricing, and vendor comments related to orders being placed at various VA Centralized Medical Operations (CMOP) facilities. This RFQ serves as a critical mechanism for ensuring the procurement of medically necessary supplies for veteran care, underscoring the importance of compliance with government contracting standards and regulations.
    Similar Opportunities
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    770-25-1-801-0016 -National CMOP NALTREXONE -(VA-25-00010070)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Naltrexone tablets as part of a procurement initiative under solicitation number 36C77025Q0036. Vendors are required to submit their quotes by 4:00 PM CT on October 28, 2024, and must include essential documentation such as a signed SF1449 Solicitation cover page, a completed quote spreadsheet, and compliance with the Drug Supply Chain Security Act. This procurement is critical for ensuring the availability of pharmaceuticals necessary for the healthcare of veterans, reflecting the government's commitment to quality service. Interested vendors can contact Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162 for further information.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0046 770-25-1-801-0022 -National CMOP K0016 KETOCONAZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the National CMOP Contracting Office, is seeking to procure Ketoconazole 2% shampoo in various quantities for emergency delivery to multiple Compounding Medication Order Pharmacy (CMOP) facilities across the United States. The procurement includes specific item quantities, with a total of 27,600 units required, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to U.S. trade agreements. This acquisition is crucial for ensuring that veterans receive necessary pharmaceutical products in a timely manner. Interested vendors must submit their quotes by November 1, 2024, with an estimated award date of November 6, 2024, and should direct all inquiries and submissions to Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0045 762-25-1-040-0082 -Tucson CMOP KETOCANOZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of 27,192 units of Ketoconazole 2% Shampoo, specifically packaged in 120ML bottles, to be delivered to the Tucson CMOP facility in Arizona. This presolicitation notice (Solicitation Number: 36C77025Q0045) outlines the requirement for vendors to submit a complete solicitation package, including a signed SF1449 cover page, a price schedule in Excel format, and proof of state licensure in compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is crucial for ensuring the availability of essential pharmaceuticals for veteran care, with a delivery timeframe of 10 days after receipt of order (ARO) and a closing date for responses set for November 1, 2024, at 09:00 AM Central Time. Interested vendors should direct their inquiries and submissions to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0041 762-25-1-040-0052 -Tucson CMOP 2 PHARMACEUTICALS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, Arizona, under solicitation number 36C77025Q0041. The procurement includes specific quantities of Dorzolamide HCL 2% ophthalmic solution and Zolmitriptan 5mg nasal spray, which are critical for the healthcare services provided to veterans. Compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory, requiring vendors to submit documentation such as a state wholesale distributor license and a completed Trade Agreements Certificate. Interested parties must submit their quotations by October 30, 2024, at 09:00 AM CST, with the anticipated award date set for November 4, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.